QPS Announces New Laboratory Services for Clinical Trials and Cell Therapy Development
26 Junio 2024 - 1:59PM
Business Wire
QPS, a leading global contract research organization (CRO), is
pleased to announce new laboratory services capabilities. The
central laboratory, leukopak cell therapy facility, and enhanced
PBMC capabilities will complement existing bioanalysis,
translational medicine and peripheral blood mononuclear cell (PMBC)
laboratories and extend the current QPS full-service global CRO
offerings.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240626261072/en/
QPS Missouri, a division of QPS Holdings,
LLC, a global Contract Research Organization. QPS Missouri conducts
Phase I-IV clinical trials and houses central lab, safety lab, PBMC
and cell production services in Springfield, Missouri. (Photo:
Business Wire)
QPS now offers clinical trial sample analysis services and
leukopak cell therapy products from its newly expanded clinical
trials unit conveniently located in Springfield, Missouri. In
addition, QPS has also expanded PBMC service offerings from its
Miami, Florida location into its Springfield, Missouri
laboratories. The new facilities are housed with an existing
clinical (safety) laboratory, a modern self-contained pharmacy, and
dedicated space to build and ship clinical trial kits.
The modern central laboratory for sample analysis complements
the existing on-site safety laboratory, equipped with the most
up-to-date technologies for chemistry, urinalysis, serology,
coagulation, and hematology testing. These capabilities, designed
to monitor subject safety during ongoing clinical trials, will
remain as core services for QPS in-house clinical trials.
The new leukopak products collection and processing facility is
designed to meet the exponential growing demand for blood products
to support cell therapy research and QPS is ideally placed to
provide this service. QPS Missouri has a database of over 35,000
potential study participants, who can be contacted as potential
blood donors for leukopak products.
“There is significant unmet demand in this rapidly growing area
of cell therapy products, which represents a tremendous opportunity
for QPS. Over 3,000 cell and gene therapy programs are currently in
progress representing a 20% increase over the past five years.
These programs require leukopak products to move forward, and as a
result this market is forecasted to grow by a CAGR of more than 8%
over the next six years,” said Benjamin Chien, Chairman, President
and CEO of QPS.
The enhanced PBMC services include a new PBMC processing lab at
the Springfield location, complementing the existing lab at QPS
Miami in Miami, Florida. This new lab will support a current unmet
need for PBMC processing in the midwestern USA. PBMC sample
analysis is a time-consuming process, typically required in vaccine
trials, and it is best done in a lab adjacent to the clinical trial
unit. QPS is uniquely positioned to offer this service.
“These new facilities, services and products extend our full
service CRO capabilities, putting QPS in a position to offer
clients comprehensive clinical research services in one location.
The central lab, PBMC lab, and the leukopack facility complement
and enhance our current 240 bed clinical trials unit, safety
laboratory, modern self-contained pharmacy, and clinical trial kit
production facility,” said Brendon Bourg, Vice President, Early
Phase Clinical and Head of Administration at QPS Missouri.
ABOUT QPS HOLDINGS, LLC
QPS is a global, full-service, GLP/GCP-compliant contract
research organization (CRO) delivering the highest grade of
discovery, bioanalysis, preclinical and clinical drug development
services. Since 1995, QPS has grown from a small bioanalysis shop
into a full-service CRO with 1,100+ employees in the US, Europe,
and Asia. Today, QPS offers expanded pharmaceutical contract
R&D services with special expertise in pharmacology, DMPK,
toxicology, bioanalysis, translational medicine, clinical trials,
and clinical research services. An award-winning leader focused on
bioanalysis and clinical trials, QPS is known for proven quality
standards, technical expertise, a flexible approach to research,
client satisfaction, and turnkey laboratories and facilities.
Through continual enhancements in capacities and resources, QPS
stands tall in its commitment to delivering superior quality,
skilled performance and trusted service to its valued customers.
For more information, visit www.qps.com or email info@qps.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240626261072/en/
Gabrielle Pastore 1-302-635-4290 Gabrielle.Pastore@qps.com